Molecular classification of patients with malignant melanoma for new therapeutic strategies.
Palmieri
Giuseppe
G
Casula
Milena
M
Ascierto
Paolo A
PA
Tanda
Francesco
F
Cossu
Antonio
A
D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage*; D048049:Extracellular Signal-Regulated MAP Kinases / Q000502:physiology; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000037:antagonists & inhibitors / Q000235:genetics; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000188:drug therapy*; D013873:Thionucleotides / Q000008:administration & dosage*
D016376:Oligonucleotides, Antisense; D019253:Proto-Oncogene Proteins c-bcl-2; D013873:Thionucleotides; D003606:Dacarbazine; C408162:oblimersen; D048049:Extracellular Signal-Regulated MAP Kinases